Inventor · disambiguated record
Marco Breinig
Also filed as: BREINIG MARCO
3 granted patents·6 pending applications·0 citations·filing 2014–2025
47Inventor score
Files withDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS4IOMX THERAPEUTICS AG3DEUTSCHES KREBSFORSCH2
Top patents by PatentIndex Score
9 records- 0164US11802285B2Cytotoxic T cell response modifiersDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2019·Granted Oct 31, 2023·0 cites·10 claims
- 0264US2025340886A1Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereofIOMX THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 0355US9994854B2Cytotoxic T cell response modifiersDEUTSCHES KREBSFORSCH·Filed 2014·Granted Jun 12, 2018·0 cites·43 claims
- 0449US2018298388A1Cytotoxic t cell response modifiersDEUTSCHES KREBSFORSCH·Filed 2018·Application pending·0 cites
- 0548US12338440B2Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereofIOMX THERAPEUTICS AG·Filed 2018·Granted Jun 24, 2025·0 cites·33 claims
- 0637US2019263906A1Immune modulators for reducing immune-resistance in melanoma and other proliferative diseasesDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2017·Application pending·0 cites
- 0736US2020164068A1Modulators of tumor immune resistance for the treatment of cancerDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2017·Application pending·0 cites
- 0835US2020024347A1Or10h1 antigen binding proteins and uses thereofIOMX THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 0933US2019054110A1Modulators of ccr9 for treating tumor resistance to immune responsesDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marco Breinig files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →